These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 3730163)
1. In vivo analysis of the Lundia 5 (PRO 5) and Lundia 3 (PRO 3) dialyzers with Gambrane polycarbonate membranes. Miller JH; Shinaberger JH; Henderson LW; Gardner PW Blood Purif; 1986; 4(1-3):63-73. PubMed ID: 3730163 [TBL] [Abstract][Full Text] [Related]
2. Performance and biocompatibility of the FD 100 Gambrane hollow-fiber dialyzer. Flöge J; Stannat S; Bahlmann J; Kühn KW; Koch KM Blood Purif; 1986; 4(1-3):112-9. PubMed ID: 3730155 [TBL] [Abstract][Full Text] [Related]
3. Performance of the Lundia PRO dialyzer. Lindholm T Blood Purif; 1986; 4(1-3):40-6. PubMed ID: 3730159 [TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of a flat plate dialyzer equipped with a polycarbonate polyether copolymer membrane. Jacobs C; Sari R Blood Purif; 1986; 4(1-3):32-9. PubMed ID: 3730158 [TBL] [Abstract][Full Text] [Related]
5. Evaluation and tolerance of a new polycarbonate membrane in elderly patients. Preliminary results. Forêt M; Hachache T; Alibeu C; Kuentz F; Meftahi H Blood Purif; 1986; 4(1-3):159-67. PubMed ID: 3488067 [TBL] [Abstract][Full Text] [Related]
6. The Lundia Pro 5 dialyzer, a polycarbonate membrane dialyzer. Nielsen B; Petersen B; Post L Blood Purif; 1986; 4(1-3):53-62. PubMed ID: 3730161 [TBL] [Abstract][Full Text] [Related]
7. Clinical investigation of the new dialyzer Gambro PRO-3. Wehle B; Oja-Pettersson K; Schyllert B; Diehl U; Bergström J Blood Purif; 1986; 4(1-3):47-52. PubMed ID: 3730160 [TBL] [Abstract][Full Text] [Related]
8. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates. Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120 [TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of a new polycarbonate dialysis membrane. Knudsen F; Nielsen AH; Pedersen JO; Grunnet N; Jersild C Blood Purif; 1986; 4(1-3):142-6. PubMed ID: 2942156 [TBL] [Abstract][Full Text] [Related]
10. Performance and biocompatibility of a new hemodialysis membrane. von Herrath D; Dati F; Pelzer H; Hartenstein K; Kutschera D; Schaefer K Blood Purif; 1986; 4(1-3):151-8. PubMed ID: 3637111 [TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo. Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156 [TBL] [Abstract][Full Text] [Related]
12. Preliminary report on complement activating potential of polycarbonate membrane. Henderson LW; Chenoweth DE; Shinaberger JH; Miller J; Konstantin P Blood Purif; 1986; 4(1-3):74-81. PubMed ID: 3730164 [TBL] [Abstract][Full Text] [Related]
13. Biocompatibility and hemodynamic studies during polycarbonate versus cuprophane membrane dialysis. Schohn DC; Jahn HA; Eber M; Hauptmann G Blood Purif; 1986; 4(1-3):102-11. PubMed ID: 3730154 [TBL] [Abstract][Full Text] [Related]
14. The influence of dialyzer geometry on blood coagulation and biocompatibility. Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717 [TBL] [Abstract][Full Text] [Related]
15. Biocompatibility of a polycarbonate membrane. A preliminary report. De Broe ME; van Waeleghem JP; Heyrman R; De Backer W Blood Purif; 1986; 4(1-3):168-71. PubMed ID: 3015165 [TBL] [Abstract][Full Text] [Related]
16. Anaphylatoxin C5a generation and dialysis-induced leukopenia with different hemodialyzer membranes. Aljama P; Martín-Malo A; Castillo D; Velasco F; Torres A; Pérez R; Castro M Blood Purif; 1986; 4(1-3):88-92. PubMed ID: 3730166 [TBL] [Abstract][Full Text] [Related]
18. Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Ronco C; Brendolan A; Lupi A; Metry G; Levin NW Kidney Int; 2000 Aug; 58(2):809-17. PubMed ID: 10916106 [TBL] [Abstract][Full Text] [Related]
19. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients. Zehnder C; Gutzwiller JP; Renggli K Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310 [TBL] [Abstract][Full Text] [Related]
20. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination]. Orłowski A; Szepietowski T Polim Med; 1992; 22(1-2):59-72. PubMed ID: 1461837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]